NYSE:DNMR
Danimer Scientific, Inc.
- Stock
Last Close
0.75
10/05 20:00
Market Cap
69.65M
Beta: 1.50
Volume Today
588.47K
Avg: 1.58M
PE Ratio
−0.43
PFCF: −0.68
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 10.34M - | 19.11M 84.79% | 28.66M 49.98% | 29.01M 1.22% | ||
average payables | 9.37M - | 15.70M 67.65% | 17.88M 13.91% | 10.13M 43.33% | ||
average receivables | 6.80M - | 16.32M 140.05% | 24.44M 49.77% | 21.60M 11.62% | ||
book value per share | 0.19 - | 14.84 7,575.99% | 5.37 63.79% | 4.06 24.52% | 2.73 32.82% | |
capex per share | -0.43 - | -1.29 203.44% | -1.99 53.93% | -1.77 11.29% | -0.27 84.64% | |
capex to depreciation | -8.99 - | -7.47 16.86% | -17.44 133.41% | -8.19 53.03% | -0.95 88.37% | |
capex to operating cash flow | 21.85 - | 2.77 87.31% | 2.94 6.17% | 2.66 9.67% | 0.59 77.98% | |
capex to revenue | -1.13 - | -0.81 28.47% | -3.16 290.36% | -3.09 2.07% | -0.59 80.81% | |
cash per share | 0.07 - | 12.77 17,382.79% | 3.08 75.89% | 0.67 78.08% | 0.58 14.01% | |
days of inventory on hand | 120.96 - | 138.79 14.74% | 155.00 11.68% | 187.82 21.17% | 111.62 40.57% | |
days payables outstanding | 139.56 - | 107.95 22.65% | 131.14 21.49% | 85.91 34.49% | 23.37 72.79% | |
days sales outstanding | 62.33 - | 62.24 0.14% | 152.59 145.18% | 166.74 9.27% | 147.65 11.45% | |
debt to assets | 0.71 - | 0.15 78.49% | 0.34 123.42% | 0.44 28.59% | 0.53 20.01% | |
debt to equity | 6.22 - | 0.19 96.93% | 0.57 200.95% | 0.83 44.70% | 1.39 67.12% | |
dividend yield | 0.06 - | 0.00 - | ||||
earnings yield | -0.02 - | -0.02 8.72% | -0.08 252.01% | -1.08 1,323.47% | -1.49 38.50% | |
enterprise value | 924.05M - | 401.39M 56.56% | 793.86M 97.78% | 417.64M 47.39% | 452.94M 8.45% | |
enterprise value over ebitda | -221.92 - | -38.98 82.44% | -8.94 77.06% | -8.66 3.14% | -4.71 45.59% | |
ev to operating cash flow | -552.33 - | -29.09 94.73% | -12.61 56.66% | -6.75 46.43% | -9.58 41.89% | |
ev to sales | 28.57 - | 8.48 70.32% | 13.51 59.35% | 7.85 41.92% | 9.70 23.63% | |
free cash flow per share | -0.45 - | -1.76 294.78% | -2.67 51.56% | -2.43 8.88% | -0.73 69.78% | |
free cash flow yield | -0.05 - | -0.07 62.04% | -0.31 318.20% | -1.36 333.72% | -0.72 46.97% | |
graham net net | -1.33 - | 9.58 819.59% | -0.23 102.37% | -2.55 1,022.45% | -3.59 40.88% | |
graham number | 1.00 - | 13.00 1,206.51% | 8.84 32.03% | 13.28 50.25% | 9.67 27.18% | |
income quality | 0.09 - | 1.10 1,179.96% | 1.05 4.54% | 0.34 67.16% | 0.30 11.63% | |
intangibles to total assets | 0.01 - | 0.00 76.77% | 0.18 5,227.36% | 0.11 35.31% | 0.11 6.26% | |
interest coverage | -2.99 - | -6.48 116.62% | -130.26 1,908.94% | -1.67 98.72% | ||
interest debt per share | 1.24 - | 2.91 134.50% | 3.10 6.19% | 4.58 47.90% | 3.79 17.30% | |
inventory turnover | 3.02 - | 2.63 12.85% | 2.35 10.46% | 1.94 17.47% | 3.27 68.27% | |
invested capital | 6.22 - | 0.19 96.93% | 0.57 200.95% | 0.83 44.70% | 1.39 67.12% | |
market cap | 827.24M - | 695.21M 15.96% | 793.02M 14.07% | 166.61M 78.99% | 104.04M 37.55% | |
net current asset value | -108.76M - | 295.09M 371.32% | 2.03M 99.31% | -209.59M 10,444.87% | -344.23M 64.24% | |
net debt to ebitda | -23.25 - | 28.53 222.72% | -0.01 100.03% | -5.20 55,318.34% | -3.63 30.27% | |
net income per share | -0.23 - | -0.51 122.38% | -0.65 27.57% | -1.93 199.06% | -1.52 21.08% | |
operating cash flow per share | -0.02 - | -0.47 2,290.74% | -0.68 44.98% | -0.66 1.79% | -0.46 30.25% | |
payables turnover | 2.62 - | 3.38 29.29% | 2.78 17.69% | 4.25 52.65% | 15.62 267.54% | |
receivables turnover | 5.86 - | 5.86 0.14% | 2.39 59.21% | 2.19 8.48% | 2.47 12.93% | |
research and ddevelopement to revenue | 0.17 - | 0.17 2.14% | 0.35 108.01% | 0.60 73.94% | 0.46 23.48% | |
return on tangible assets | -0.14 - | -0.03 79.92% | -0.09 216.22% | -0.28 227.47% | -0.24 16.32% | |
revenue per share | 0.38 - | 1.60 324.24% | 0.63 60.57% | 0.57 9.41% | 0.46 19.95% | |
roe | -1.18 - | -0.03 97.10% | -0.12 252.29% | -0.48 296.20% | -0.56 17.47% | |
roic | -0.09 - | -0.03 63.83% | -0.10 193.81% | -0.26 159.98% | -0.18 29.75% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 0.19 - | 14.84 7,575.99% | 5.37 63.79% | 4.06 24.52% | 2.73 32.82% | |
stock based compensation to revenue | 0.16 - | 0.08 52.75% | 0.94 1,121.67% | 1.07 13.76% | 1.20 12.15% | |
tangible asset value | 14.52M - | 437.10M 2,909.52% | 352.96M 19.25% | 296.67M 15.95% | 200.23M 32.51% | |
tangible book value per share | 0.17 - | 14.78 8,624.53% | 3.79 74.35% | 3.19 15.95% | 1.96 38.41% | |
working capital | -15.04M - | 351.90M 2,438.96% | 296.88M 15.63% | 99.78M 66.39% | 92.31M 7.49% |
All numbers in USD (except ratios and percentages)